Kimberly-Clark Warms To Medivance, Buys Temperature Management Tech
This article was originally published in The Gray Sheet
Executive Summary
Medivance will use up to $17 mil. in proceeds from the sale of its patient warming business to Kimberly-Clark to fund further development of its Arctic Sun patient cooling system for strokes and heart attacks
You may also be interested in...
Baxter/Cerus Pathogen Inactivation PMA Set Back Two Years For More Data
Baxter/Cerus expects the supplemental pivotal trial of its Intercept blood platelet pathogen inactivation system to take 15-18 months to complete
Baxter/Cerus Pathogen Inactivation PMA Set Back Two Years For More Data
Baxter/Cerus expects the supplemental pivotal trial of its Intercept blood platelet pathogen inactivation system to take 15-18 months to complete
Medivance Arctic Sun Temperature Management System On Horizon For Q4
Medivance will have to generate clinical data supporting a regulatory submission to FDA for the role of its Arctic Sun temperature management system in improving health outcomes in stroke patients before the firm can make any direct therapeutic claims about the device.